A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

Paz-Ares, Luis; Vicente, David; Tafreshi, Ali; Robinson, Andrew; Parra, Hector Soto; Mazieres, Julien; Hermes, Barbara; Cicin, Irfan; Medgyasszay, Balazs; Rodriguez-Cid, Jeronimo; Okamoto, Isamu; Lee, SungSook; Ramlau, Rodryg; Vladimirov, Vladimir; Cheng, Ying; Deng, Xuan; Zhang, Ying; Bas, Tuba; Piperdi, Bilal; Halmos, Balazs

A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407

Autor(en):

Paz-Ares, Luis; Vicente, David; Tafreshi, Ali; Robinson, Andrew; Parra, Hector Soto; Mazieres, Julien; Hermes, Barbara; Cicin, Irfan; Medgyasszay, Balazs; Rodriguez-Cid, Jeronimo; Okamoto, Isamu; Lee, SungSook; Ramlau, Rodryg; Vladimirov, Vladimir; Cheng, Ying; Deng, Xuan; Zhang, Ying; Bas, Tuba; Piperdi, Bilal; Halmos, Balazs

Tübinger Autor(en):

Hermes, Barbara

Erschienen in:

Journal of Thoracic Oncology (2020), Bd. 15, H. 10, S. 1657-1669

Verlagsangabe:

Elsevier Science Inc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1016/j.jtho.2020.06.015

ISSN:

1556-1380